The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Surg.
Sec. Reconstructive and Plastic Surgery
Volume 11 - 2024 |
doi: 10.3389/fsurg.2024.1477023
This article is part of the Research Topic Recent Innovations in Breast Reconstructive Surgery: a continuous debate View all 4 articles
Microbiology of periprosthetic infections following implantbased breast reconstruction surgery: a multicentric retrospective study
Provisionally accepted- 1 Division of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy
- 2 Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy
- 3 PhD Program in Applied Medical-Surgical Sciences-Department of Surgical Sciences, University of Rome "Tor Vergata", Rome, Italy
- 4 Senior Resident in Plastic Surgery, University Hospital of Modena, Modena, Italy
- 5 Division of Plastic and Reconstructive Surgery, IRCCS University Hospital of Bologna Sant Orsola Polyclinic, Bologna, Emilia-Romagna, Italy
- 6 Division of Plastic and Reconstructive Surgery, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
- 7 Division of Breast Surgery, European Institute of Oncology (IEO), Milan, Italy
- 8 Division of Infectious Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
Introduction: Implant-based breast reconstruction (IBR) is the predominant breast reconstruction technique post-mastectomy, with bacterial infections being a significant complication affecting patient recovery and quality of life. The following study aimed to determine the microbiological features of the causative agents responsible for breast implant infections, with more attention paid to the comparative analysis of Gram-positive and Gram-negative bacteria and their presentation. Methods: We conducted a retrospective analysis of 214 patients who presented with periprosthetic infection and underwent implant removal following implant-based breast
Keywords: Breast implant infection, gram positive bacteria, Multiresistant bacteria, Breast reconstruction, complications
Received: 06 Aug 2024; Accepted: 27 Aug 2024.
Copyright: © 2024 Lisa, Zeneli, Mazzucco, Barbieri, Rietjens, Lissidini, Vinci, Bartoletti, Belati and Bavaro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Andrea V. Lisa, Division of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy
Flavia Zeneli, Senior Resident in Plastic Surgery, University Hospital of Modena, Modena, Italy
Benedetta Barbieri, Division of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy
Mario Rietjens, Division of Plastic and Reconstructive Surgery, European Institute of Oncology, Milan, Italy
Germana Lissidini, Division of Breast Surgery, European Institute of Oncology (IEO), Milan, Italy
Alessandra Belati, Division of Infectious Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
Davide Bavaro, Division of Infectious Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.